Literature DB >> 8196606

Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts.

C Sell1, G Dumenil, C Deveaud, M Miura, D Coppola, T DeAngelis, R Rubin, A Efstratiadis, R Baserga.   

Abstract

Fibroblast cell lines, designated R- and W cells, were generated, respectively, from mouse embryos homozygous for a targeted disruption of the Igf1r gene, encoding the type 1 insulin-like growth factor receptor, and from their wild-type littermates. W cells grow normally in serum-free medium supplemented with various combinations of purified growth factors, while pre- and postcrisis R- cells cannot grow, as they are arrested before entering the S phase. R- cells are able to grow in 10% serum, albeit more slowly than W cells, and with all phases of the cell cycle being elongated. An activated Ha-ras expressed from a stably transfected plasmid is unable to overcome the inability of R- cells to grow in serum-free medium supplemented with purified clones. Nevertheless, even in the presence of serum, R- cells stably transfected with Ha-ras, alone or in combination with simian virus 40 large T antigen, fail to form colonies in soft agar. Reintroduction into R- cells (or their derivatives) of a plasmid expressing the human insulin-like growth factor I receptor RNA and protein restores their ability to grow with purified growth factors or in soft agar. The signaling pathways participating in cell growth and transformation are discussed on the basis of these results.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8196606      PMCID: PMC358728          DOI: 10.1128/mcb.14.6.3604-3612.1994

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  61 in total

Review 1.  Insulin-like growth factors and their binding proteins.

Authors:  V R Sara; K Hall
Journal:  Physiol Rev       Date:  1990-07       Impact factor: 37.312

2.  Transphosphorylation as a possible mechanism for insulin and epidermal growth factor receptor activation.

Authors:  R Lammers; E Van Obberghen; R Ballotti; J Schlessinger; A Ullrich
Journal:  J Biol Chem       Date:  1990-10-05       Impact factor: 5.157

3.  Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signalling.

Authors:  N Li; A Batzer; R Daly; V Yajnik; E Skolnik; P Chardin; D Bar-Sagi; B Margolis; J Schlessinger
Journal:  Nature       Date:  1993-05-06       Impact factor: 49.962

4.  The pathway to signal achievement.

Authors:  S E Egan; R A Weinberg
Journal:  Nature       Date:  1993-10-28       Impact factor: 49.962

Review 5.  Cell cycle and growth control.

Authors:  R Baserga; R Rubin
Journal:  Crit Rev Eukaryot Gene Expr       Date:  1993       Impact factor: 1.807

6.  Inhibition of the mitogenic effects of plasma by a monoclonal antibody to somatomedin C.

Authors:  W E Russell; J J Van Wyk; W J Pledger
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

7.  Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts.

Authors:  D E Quelle; R A Ashmun; S A Shurtleff; J Y Kato; D Bar-Sagi; M F Roussel; C J Sherr
Journal:  Genes Dev       Date:  1993-08       Impact factor: 11.361

8.  Cyclin D1 messenger RNA is inducible by platelet-derived growth factor in cultured fibroblasts.

Authors:  E Surmacz; K Reiss; C Sell; R Baserga
Journal:  Cancer Res       Date:  1992-08-15       Impact factor: 12.701

9.  Roles of insulinlike growth factor 1 (IGF-1) and the IGF-1 receptor in epidermal growth factor-stimulated growth of 3T3 cells.

Authors:  Z Pietrzkowski; C Sell; R Lammers; A Ullrich; R Baserga
Journal:  Mol Cell Biol       Date:  1992-09       Impact factor: 4.272

10.  Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1.

Authors:  I A Drummond; S L Madden; P Rohwer-Nutter; G I Bell; V P Sukhatme; F J Rauscher
Journal:  Science       Date:  1992-07-31       Impact factor: 47.728

View more
  148 in total

1.  Disruption of imprinted genes at chromosome region 11p15.5 in paediatric rhabdomyosarcoma.

Authors:  J Anderson; A Gordon; A McManus; J Shipley; K Pritchard-Jones
Journal:  Neoplasia       Date:  1999-10       Impact factor: 5.715

2.  Sortilin regulates progranulin action in castration-resistant prostate cancer cells.

Authors:  Ryuta Tanimoto; Alaide Morcavallo; Mario Terracciano; Shi-Qiong Xu; Manuela Stefanello; Simone Buraschi; Kuojung G Lu; Demetrius H Bagley; Leonard G Gomella; Katia Scotlandi; Antonino Belfiore; Renato V Iozzo; Andrea Morrione
Journal:  Endocrinology       Date:  2015-01       Impact factor: 4.736

3.  Serum IGF1, IGF2 and IGFBP3 and risk of advanced colorectal adenoma.

Authors:  Ying Gao; Hormuzd Katki; Barry Graubard; Michael Pollak; Michael Martin; Yuzhen Tao; Robert E Schoen; Timothy Church; Richard B Hayes; Mark H Greene; Sonja I Berndt
Journal:  Int J Cancer       Date:  2011-11-02       Impact factor: 7.396

Review 4.  Roles for growth factors in cancer progression.

Authors:  Esther Witsch; Michael Sela; Yosef Yarden
Journal:  Physiology (Bethesda)       Date:  2010-04

Review 5.  Progranulin: a growth factor, a novel TNFR ligand and a drug target.

Authors:  Chuan-ju Liu; Xavier Bosch
Journal:  Pharmacol Ther       Date:  2011-10-08       Impact factor: 12.310

6.  Proepithelin regulates prostate cancer cell biology by promoting cell growth, migration, and anchorage-independent growth.

Authors:  Giada Monami; Velia Emiliozzi; Alessandro Bitto; Francesca Lovat; Shi-Qiong Xu; Silvia Goldoni; Matteo Fassan; Ginette Serrero; Leonard G Gomella; Raffaele Baffa; Renato V Iozzo; Andrea Morrione
Journal:  Am J Pathol       Date:  2009-01-29       Impact factor: 4.307

7.  Igf1r as a therapeutic target in a mouse model of basal-like breast cancer.

Authors:  Apostolos Klinakis; Matthias Szabolcs; Guoying Chen; Shouhong Xuan; Hanina Hibshoosh; Argiris Efstratiadis
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-27       Impact factor: 11.205

8.  IGF1R inhibition in mammary epithelia promotes canonical Wnt signaling and Wnt1-driven tumors.

Authors:  Lauren M Rota; Lidia Albanito; Marcus E Shin; Corey L Goyeneche; Sain Shushanov; Emily J Gallagher; Derek LeRoith; Deborah A Lazzarino; Teresa L Wood
Journal:  Cancer Res       Date:  2014-08-04       Impact factor: 12.701

9.  Antiproliferative and proapoptotic effect of ascorbyl stearate in human pancreatic cancer cells: association with decreased expression of insulin-like growth factor 1 receptor.

Authors:  K Akhilender Naidu; Richard C Karl; Kamatham A Naidu; Domenico Coppola
Journal:  Dig Dis Sci       Date:  2003-01       Impact factor: 3.199

10.  Association of insulin receptor substrate 1 with simian virus 40 large T antigen.

Authors:  Z L Fei; C D'Ambrosio; S Li; E Surmacz; R Baserga
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.